Radiant Innovation

Radiant Innovation Financing Cash Flow

The Net Financing Cash Flow of Radiant Innovation (3373.TWO) as of Nov 20, 2026 is -432.95 M TWD. In the previous year, Net Financing Cash Flow was -86.58 M TWD — a change of 400.06% (lower).

Financing Cash Flow

-432.95 MTWD

YoY

400.06%

Last updated:

Net Financing Cash Flow of Radiant Innovation is 2021 -432.95 M TWD. Net Financing Cash Flow of Radiant Innovation was 2020 -86.58 M TWD. It decreases by 400.06% lower compared to the previous year.

The Radiant Innovation Financing Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financing Cash Flow
Date
Financing Cash Flow
Jan 1, 2014
205.76 M TWD
Jan 1, 2015
-29.80 M TWD
Jan 1, 2016
-60.73 M TWD
Jan 1, 2017
-21.59 M TWD
Jan 1, 2018
-12.99 M TWD
Jan 1, 2019
-21.64 M TWD
Jan 1, 2020
-86.58 M TWD
Jan 1, 2021
-432.95 M TWD
The Radiant Innovation Financing Cash Flow history
YEARFinancing Cash FlowYoY
-432.95 MTWD+400.06%
-86.58 MTWD+300.02%
-21.64 MTWD+66.66%
-12.99 MTWD-39.85%
-21.59 MTWD-64.45%
-60.73 MTWD+103.80%
-29.80 MTWD-114.48%
205.76 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Radiant Innovation Stock analysis

What does Radiant Innovation do? Radiant Innovation Inc. generates revenue through the design, manufacture, and sale of infrared technology products. The company's main products include infrared temperature measurement instruments, ear temperature guns, frontal temperature guns, and other body temperature measurement products, alongside carbon dioxide detectors, infrared thermal imagers, and blood glucose dedicated chipsets. These products are distributed domestically and internationally across Asia, the Americas, Europe, and other regions. The primary buyers are healthcare providers, medical facilities, and electronic component distributors who require precise measurement tools and specialized components for health monitoring and diagnostics. The firm's product portfolio targets healthcare and industrial segments, with infrared thermal imagers used in building inspections and carbon dioxide detectors deployed in environmental monitoring. Blood glucose dedicated chipsets are supplied to medical device manufacturers for integration into diagnostic equipment. International distribution channels focus on regions like Asia, the Americas, and Europe, where demand for health-related measurement devices remains strong. Revenue streams are driven by direct sales to medical institutions, electronic component distributors, and industrial clients. The company's product lines serve both consumer-facing health monitoring applications and specialized industrial uses, with a strong emphasis on accuracy and reliability in temperature and gas detection technologies. Radiant Innovation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Radiant Innovation stock

Net Financing Cash Flow of Radiant Innovation is -432.95 M TWD in 2021.

Net Financing Cash Flow of Radiant Innovation changed from -86.58 M TWD to -432.95 M TWD, representing a 400.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Financing Cash Flow Radiant Innovation since 2006 – with annual values, charts, and detailed analysis.

Financing cash flow measures cash flows from debt issuance/repayment, equity transactions, and dividend payments.

Net Financing Cash Flow's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Financing Cash Flow's Radiant Innovation historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Radiant Innovation

All Key Metrics — Radiant Innovation